MEDICARTA Trademark

Trademark Overview


On Wednesday, September 29, 2021, a trademark application was filed for MEDICARTA with the United States Patent and Trademark Office. The USPTO has given the MEDICARTA trademark a serial number of 97052514. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Thursday, October 3, 2024. This trademark is owned by Rampart Bioscience, Inc.. The MEDICARTA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Providing online non-downloadable software via a web-based clinical and patient portal that permits the collection and distribution of information regarding therapeutics, treatment and research; providing temporary use of a web-based software application for use in clinical trials and clinical development to inform patients; providing temporary use of a web-based software application for use in clinical trials and clinical development to collect data; providing temporary use of a web-based software application for use in clinical trials and clinical development to track clinical developments; providing temporary use of non-downloadable cloud-based software for use in clinical trials and clinical development to inform patients; providing temporary use of non-downloadable cloud-based software for use in clinical trials and clinical development to collect data; providing temporary use of non-downloadable cloud-based software for use in clinical trials and clinical development to track cli...
medicarta

General Information


Serial Number97052514
Word MarkMEDICARTA
Filing DateWednesday, September 29, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateThursday, October 3, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 9, 2022

Trademark Statements


Goods and ServicesProviding online non-downloadable software via a web-based clinical and patient portal that permits the collection and distribution of information regarding therapeutics, treatment and research; providing temporary use of a web-based software application for use in clinical trials and clinical development to inform patients; providing temporary use of a web-based software application for use in clinical trials and clinical development to collect data; providing temporary use of a web-based software application for use in clinical trials and clinical development to track clinical developments; providing temporary use of non-downloadable cloud-based software for use in clinical trials and clinical development to inform patients; providing temporary use of non-downloadable cloud-based software for use in clinical trials and clinical development to collect data; providing temporary use of non-downloadable cloud-based software for use in clinical trials and clinical development to track clinical developments

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, July 6, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameRampart Bioscience, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTucson, AZ 85749

Party NameRampart Bioscience, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTucson, AZ 85749

Trademark Events


Event DateEvent Description
Saturday, October 2, 2021NEW APPLICATION ENTERED
Wednesday, October 27, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, June 29, 2022ASSIGNED TO EXAMINER
Wednesday, July 6, 2022EXAMINERS AMENDMENT -WRITTEN
Wednesday, July 6, 2022EXAMINERS AMENDMENT E-MAILED
Wednesday, July 6, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, July 6, 2022EXAMINER'S AMENDMENT ENTERED
Wednesday, July 6, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 20, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 9, 2022PUBLISHED FOR OPPOSITION
Tuesday, August 9, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 4, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 4, 2023SOU EXTENSION 1 FILED
Wednesday, April 5, 2023TEAS PETITION TO REVIVE RECEIVED
Wednesday, April 5, 2023PETITION TO REVIVE-GRANTED
Wednesday, April 5, 2023SOU EXTENSION RECEIVED WITH TEAS PETITION
Wednesday, April 5, 2023NOTICE OF REVIVAL - E-MAILED
Wednesday, May 24, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, June 7, 2023SOU EXTENSION 1 GRANTED
Thursday, June 8, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 3, 2023SOU TEAS EXTENSION RECEIVED
Thursday, April 4, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, October 3, 2023SOU EXTENSION 2 FILED
Tuesday, October 3, 2023SOU EXTENSION 2 GRANTED
Thursday, October 5, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 4, 2024SOU EXTENSION 3 FILED
Thursday, April 4, 2024SOU EXTENSION 3 GRANTED
Thursday, October 3, 2024SOU TEAS EXTENSION RECEIVED
Thursday, October 3, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 3, 2024SOU EXTENSION 4 FILED
Thursday, October 3, 2024SOU EXTENSION 4 GRANTED
Tuesday, April 9, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED